Cash flow Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 14/04/2026			5-day change	1st Jan Change
199,100.00 ^KRW	+2.00%		+2.79%	+10.00%

04-08	Nomura Adjusts Celltrion's Price Target to KRW270,000 From KRW240,000, Keeps at Buy	MT
04-03	South Korean shares fall for second week on Middle East worries	RE

09840b2b58c80604b3af8274.13dlzHEdV-bk6xw4EgujYIanCKEYbDwBFM9gNyi6FVo.iDgt-0IqANGxjkpOZW_UMr7gO5JaXAVgIIkMUULRUBOCGyKCE00w0omnTQ

Published financial data: CELLTRION, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1,912B	2,284B	2,176B	3,557B	4,162B
Other Revenues, Total	-30	-10	-10	-10	-10
Total Revenues	1,912B	2,284B	2,176B	3,557B	4,162B
Cost of Goods Sold, Total	806B	1,251B	1,125B	1,876B	1,695B
Gross Profit	1,106B	1,033B	1,052B	1,682B	2,467B
Selling General & Admin Expenses, Total	186B	205B	203B	750B	923B
Provision for Bad Debts	14.31M	-1.69M	-5.03B	1.03B	7.11B
R&D Expenses	126B	140B	161B	200B	211B
Depreciation & Amortization - (IS)	2.8B	3.46B	5.35B	12.92B	17.16B
Amortization of Goodwill and Intangible Assets - (IS)	34.25B	37.35B	35.61B	161B	50.98B
Other Operating Expenses	-	-	-	64.9B	93.27B
Other Operating Expenses, Total	349B	385B	400B	1,190B	1,302B
Operating Income	757B	647B	651B	492B	1,165B
Interest Expense, Total	-8.24B	-7.51B	-9.67B	-75.57B	-75.47B
Interest And Investment Income	4.4B	14.22B	19.06B	33.53B	23.18B
Net Interest Expenses	-3.84B	6.71B	9.4B	-42.04B	-52.29B
Income (Loss) On Equity Invest.	-4.97B	7.35B	-12.68B	-3.43B	-16.73B
Currency Exchange Gains (Loss)	32.91B	16.99B	11.62B	144B	177B
Other Non Operating Income (Expenses)	-6.31B	-41.41B	355M	-1.54B	-118B
EBT, Excl. Unusual Items	775B	637B	660B	589B	1,154B
Gain (Loss) On Sale Of Investments	1.15B	-	1.51B	80.47M	-
Gain (Loss) On Sale Of Assets	32.88B	828M	13.35B	4.07B	90.56M
Asset Writedown	-57.35B	-11.49B	-3.88B	-16.92B	-614M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	751B	626B	671B	576B	1,154B
Income Tax Expense	156B	94.83B	131B	157B	122B
Earnings From Continuing Operations	596B	531B	540B	419B	1,031B
Earnings Of Discontinued Operations	-	11.22B	-	-	-
Net Income to Company	596B	543B	540B	419B	1,031B
Minority Interest	-16.31B	-4.73B	-4.06B	3.81B	-1.87B
Net Income - (IS)	579B	538B	536B	423B	1,030B
Net Income to Common Incl Extra Items	579B	538B	536B	423B	1,030B
Net Income to Common Excl. Extra Items	579B	527B	536B	423B	1,030B
Per Share Items
Net EPS - Basic	3.66K	3.43K	3.44K	1.88K	4.67K
Basic EPS - Continuing Operations	3.66K	3.36K	3.44K	1.88K	4.67K
Basic Weighted Average Shares Outstanding	158M	157M	156M	225M	221M
Net EPS - Diluted	3.62K	3.42K	3.44K	1.87K	4.66K
Diluted EPS - Continuing Operations	3.62K	3.35K	3.44K	1.87K	4.66K
Diluted Weighted Average Shares Outstanding	159M	157M	156M	226M	221M
Normalized Basic EPS	2.96K	2.51K	2.63K	1.65K	3.26K
Normalized Diluted EPS	2.94K	2.5K	2.62K	1.65K	3.26K
Dividend Per Share	647.45	330.2	457.88	686.81	750
Payout Ratio	0	19.05	9.64	24.51	14.93
Supplemental Items
EBITDA	971B	874B	897B	910B	1,452B
EBITA	909B	809B	833B	838B	1,359B
EBIT	757B	647B	651B	492B	1,165B
EBITDAR	971B	874B	898B	-	-
Effective Tax Rate - (Ratio)	20.7	15.14	19.58	27.29	10.59
Normalized Net Income	468B	393B	409B	372B	720B
Interest Capitalized	8.13B	16.38B	32.62B	20.69B	-
Supplemental Operating Expense Items
Advertising Expense	12.77B	15.09B	17.33B	93.56B	125B
Selling and Marketing Expenses	53.4B	59.67B	76.92B	379B	468B
General and Administrative Expenses	22.8B	3.3B	7.23B	8.93B	11.91B
Research And Development Expense From Footnotes	126B	140B	161B	200B	211B
Net Rental Expense, Total	337M	345M	370M	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	9.46B	11.23B	11.98B	26.84B	22.99B
Total Stock-Based Compensation	9.46B	11.23B	11.98B	26.84B	22.99B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1,188B	551B	565B	996B	1,119B
Short Term Investments	31.58B	43.28B	193B	147B	118B
Trading Asset Securities, Total	-	-	-	-	2.37B
Total Cash And Short Term Investments	1,220B	594B	757B	1,143B	1,239B
Accounts Receivable, Total	1,101B	1,622B	939B	1,215B	1,790B
Other Receivables	20.82B	13.15B	8.82B	43.7B	49.28B
Notes Receivable	42.47B	19.05B	1.25B	1.13B	1.75B
Total Receivables	1,164B	1,654B	949B	1,260B	1,841B
Inventory	578B	616B	3,041B	2,766B	2,803B
Prepaid Expenses	11.3B	13.43B	17.77B	25.12B	39.28B
Other Current Assets, Total	101B	51.46B	115B	390B	282B
Total Current Assets	3,074B	2,930B	4,881B	5,584B	6,205B
Gross Property Plant And Equipment	1,423B	1,544B	1,816B	1,710B	2,462B
Accumulated Depreciation	-473B	-537B	-602B	-466B	-760B
Net Property Plant And Equipment	950B	1,007B	1,215B	1,245B	1,703B
Long-term Investments	89.28B	118B	135B	161B	170B
Goodwill	33.01B	35.16B	11,475B	11,914B	11,878B
Other Intangibles, Total	287B	265B	502B	390B	374B
Accounts Receivable Long-Term	0	62.89B	0	0	16.26B
Loans Receivable Long-Term	0	131M	131M	247M	275M
Deferred Tax Assets Long-Term	28.62B	32.18B	63.47B	194B	293B
Deferred Charges Long-Term	1,172B	1,322B	1,358B	1,398B	1,527B
Other Long-Term Assets, Total	39.77B	119B	287B	170B	169B
Total Assets	5,674B	5,892B	19,918B	21,055B	22,335B
Liabilities
Accounts Payable, Total	80.72B	50.27B	50.85B	75.31B	125B
Accrued Expenses, Total	139B	157B	187B	150B	192B
Short-term Borrowings	512B	554B	1,608B	1,989B	3,240B
Current Portion of Long-Term Debt	54.48B	81.43B	168B	86.2B	63.5B
Current Portion of Leases	3.01B	2.73B	8.17B	11.67B	13.5B
Current Income Taxes Payable	180B	88.7B	57.04B	218B	28.14B
Unearned Revenue Current, Total	3.58B	6.77B	21.71B	18.18B	15.76B
Other Current Liabilities	238B	353B	370B	638B	777B
Total Current Liabilities	1,210B	1,294B	2,471B	3,187B	4,454B
Long-Term Debt	170B	152B	99.13B	86.6B	387B
Long-Term Leases	4.37B	2.89B	7.98B	19.09B	25.07B
Unearned Revenue Non Current	28.23B	23.01B	77.4B	73.49B	46.97B
Pension & Other Post Retirement Benefits	-	3.35B	-	-	-
Deferred Tax Liability Non Current	21.58B	1.11B	120B	99.26B	56.77B
Other Non Current Liabilities	189B	141B	17.1B	9.6B	12.55B
Total Liabilities	1,624B	1,617B	2,792B	3,475B	4,982B
Common Stock, Total	138B	141B	220B	221B	239B
Additional Paid In Capital	856B	871B	14,790B	14,828B	14,215B
Retained Earnings	3,052B	3,485B	3,964B	3,744B	4,407B
Treasury Stock	-226B	-502B	-2,204B	-2,108B	-2,186B
Comprehensive Income and Other	96.23B	144B	211B	754B	532B
Total Common Equity	3,917B	4,139B	16,981B	17,439B	17,208B
Minority Interest	133B	135B	145B	141B	144B
Total Equity	4,050B	4,274B	17,126B	17,580B	17,353B
Total Liabilities And Equity	5,674B	5,892B	19,918B	21,055B	22,335B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	158M	156M	226M	224M	219M
ECS Total Common Shares Outstanding	158M	156M	226M	224M	219M
Book Value / Share	24.75K	26.45K	75.05K	77.9K	78.72K
Tangible Book Value	3,598B	3,839B	5,003B	5,135B	4,957B
Tangible Book Value Per Share	22.73K	24.53K	22.11K	22.94K	22.67K
Total Debt	744B	792B	1,890B	2,193B	3,729B
Net Debt	-476B	198B	1,133B	1,050B	2,490B
Debt Equivalent Oper. Leases	2.69B	2.76B	2.96B	-	-
Minority Interest, Total (Incl. Fin. Div)	133B	135B	145B	141B	144B
Equity Method Investments, Total	64.84B	88.54B	105B	112B	106B
Inventories - Raw Materials, Total	245B	295B	279B	330B	523B
Inventories - Work In Process, Total	39.7B	48.31B	78.63B	103B	88.1B
Inventories - Finished Goods, Total	359B	365B	2,727B	2,386B	2,229B
Inventories - Others	2.2B	11.51B	10.2B	13.37B	9.4B
Land - (BS)	302B	302B	302B	302B	321B
Buildings, Total	373B	373B	601B	601B	802B
Machinery, Total	684B	700B	723B	724B	1,127B
Accumulated Allowance for Doubtful Accounts (Supple)	1.36B	1.53B	313M	2.48B	5.67B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	579B	538B	536B	423B	1,030B
Depreciation & Amortization - CF	61.96B	64.72B	63.78B	72.61B	92.78B
Amortization of Goodwill and Intangible Assets - (CF)	152B	162B	182B	346B	195B
Depreciation & Amortization, Total	214B	226B	246B	418B	288B
(Gain) Loss From Sale Of Asset	-23.92B	880M	-1.96B	-44.16B	-90.56M
(Gain) Loss on Sale of Investments - (CF)	-10B	-838M	-12.83B	56.79B	6.15B
Asset Writedown & Restructuring Costs	57.23B	10.62B	3.82B	151M	614M
(Income) Loss On Equity Investments - (CF)	4.97B	-15.68B	12.68B	3.43B	17.42B
Stock-Based Compensation (CF)	22.05B	25.73B	27.77B	45.22B	38.7B
Provision and Write-off of Bad Debts	-235M	7.51B	-5.08B	1.03B	3.18B
Other Operating Activities, Total	67.83B	-43.44B	-47.3B	19.81B	-242B
Change In Accounts Receivable	109B	-683B	-296B	-174B	-344B
Change In Inventories	-268B	-215B	57.25B	225B	-135B
Change In Accounts Payable	44.08B	53.57B	-2.19B	-144B	-149B
Change in Other Net Operating Assets	114B	96.19B	19.53B	72.18B	133B
Cash from Operations	911B	864M	537B	902B	646B
Capital Expenditure	-63.38B	-111B	-210B	-135B	-108B
Sale of Property, Plant, and Equipment	13.42M	3.46M	11.51M	38.76M	29.62M
Cash Acquisitions	-	-3.49B	374B	-28.69B	-536B
Divestitures	-	17.49B	-	-	-
Sale (Purchase) of Intangible assets	-230B	-201B	-141B	-195B	-223B
Investment in Marketable and Equity Securities, Total	-57.03B	-39.37B	-186B	-30.38B	-11.89B
Other Investing Activities, Total	-5.07B	40.29B	23.55B	220B	18.44B
Cash from Investing	-356B	-297B	-139B	-169B	-860B
Long-Term Debt Issued, Total	207B	181B	828B	2,137B	3,386B
Total Debt Issued	207B	181B	828B	2,137B	3,386B
Long-Term Debt Repaid, Total	-243B	-135B	-206B	-1,891B	-1,913B
Total Debt Repaid	-243B	-135B	-206B	-1,891B	-1,913B
Issuance of Common Stock	21.49B	9.86B	7.36B	21.13B	11.93B
Repurchase of Common Stock	-39.13B	-281B	-919B	-439B	-908B
Common & Preferred Stock Dividends Paid	-3.78M	-102B	-51.66B	-104B	-154B
Common & Preferred Stock Dividends Paid	-3.78M	-102B	-51.66B	-104B	-154B
Other Financing Activities, Total	-16.04B	-22.7B	-43.95B	-77.72B	-84.16B
Cash from Financing	-69.28B	-350B	-385B	-353B	339B
Foreign Exchange Rate Adjustments	17.98B	9.27B	246M	52.38B	-2.17B
Miscellaneous Cash Flow Adjustments	-	-	-	-	-130
Net Change in Cash	504B	-637B	13.43B	432B	123B
Supplemental Items
Cash Interest Paid	16.02B	22.67B	41.77B	75.22B	82.8B
Cash Income Tax Paid (Refund)	136B	217B	154B	145B	444B
Levered Free Cash Flow	517B	-140B	-1,449B	513B	172B
Unlevered Free Cash Flow	522B	-135B	-1,443B	560B	219B
Change In Net Working Capital	-119B	465B	1,757B	-138B	488B
Net Debt Issued / Repaid	-35.59B	45.62B	622B	246B	1,474B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.85	6.99	3.16	1.5	3.35
Return on Total Capital	10.52	8.2	3.38	1.59	3.56
Return On Equity %	15.93	12.77	5.04	2.41	5.91
Return on Common Equity	16.04	13.07	5.07	2.46	5.94
Margin Analysis
Gross Profit Margin %	57.85	45.22	48.33	47.27	59.27
SG&A Margin	9.74	8.97	9.34	21.08	22.18
EBITDA Margin %	50.8	38.25	41.23	25.59	34.88
EBITA Margin %	47.55	35.41	38.3	23.55	32.66
EBIT Margin %	39.59	28.34	29.93	13.83	27.98
Income From Continuing Operations Margin %	31.17	23.26	24.8	11.78	24.78
Net Income Margin %	30.31	23.55	24.61	11.88	24.74
Net Avail. For Common Margin %	30.31	23.06	24.61	11.88	24.74
Normalized Net Income Margin	24.47	17.22	18.77	10.45	17.29
Levered Free Cash Flow Margin	27.04	-6.13	-66.58	14.42	4.13
Unlevered Free Cash Flow Margin	27.31	-5.92	-66.31	15.75	5.26
Asset Turnover
Asset Turnover	0.36	0.39	0.17	0.17	0.19
Fixed Assets Turnover	2.02	2.33	1.96	2.89	2.82
Receivables Turnover (Average Receivables)	1.62	1.68	1.7	3.3	2.77
Inventory Turnover (Average Inventory)	1.67	2.1	0.61	0.65	0.61
Short Term Liquidity
Current Ratio	2.54	2.26	1.98	1.75	1.39
Quick Ratio	1.93	1.72	0.69	0.75	0.69
Operating Cash Flow to Current Liabilities	0.75	0	0.22	0.28	0.15
Days Sales Outstanding (Average Receivables)	224.69	217.58	214.75	110.83	131.78
Days Outstanding Inventory (Average Inventory)	217.96	174.21	593.61	566.36	599.49
Average Days Payable Outstanding	20.94	18.54	5.2	14.4	21.05
Cash Conversion Cycle (Average Days)	421.71	373.25	803.16	662.78	710.22
Long Term Solvency
Total Debt/Equity	18.38	18.54	11.04	12.47	21.49
Total Debt / Total Capital	15.52	15.64	9.94	11.09	17.69
LT Debt/Equity	4.31	3.61	0.63	0.6	2.38
Long-Term Debt / Total Capital	3.64	3.05	0.56	0.53	1.96
Total Liabilities / Total Assets	28.62	27.45	14.02	16.5	22.31
EBIT / Interest Expense	91.88	86.21	67.4	6.51	15.43
EBITDA / Interest Expense	117.87	116.36	92.83	12.04	19.24
(EBITDA - Capex) / Interest Expense	110.18	101.55	71.1	10.26	17.81
Total Debt / EBITDA	0.77	0.91	2.11	2.41	2.57
Net Debt / EBITDA	-0.49	0.23	1.26	1.15	1.71
Total Debt / (EBITDA - Capex)	0.82	1.04	2.75	2.83	2.77
Net Debt / (EBITDA - Capex)	-0.52	0.26	1.65	1.35	1.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.38	20.63	-4.71	63.45	17.01
Gross Profit, 1 Yr. Growth %	7.6	-5.05	1.86	59.88	46.7
EBITDA, 1 Yr. Growth %	8.8	-8.84	2.71	1.45	59.52
EBITA, 1 Yr. Growth %	8.9	-9.76	3.04	0.5	62.27
EBIT, 1 Yr. Growth %	5.32	-13.03	0.65	-24.47	136.69
Earnings From Cont. Operations, 1 Yr. Growth %	13.33	-9.3	1.57	-22.39	146.25
Net Income, 1 Yr. Growth %	11.92	-7.18	-0.41	-21.09	143.58
Normalized Net Income, 1 Yr. Growth %	16.6	-14.48	3.87	-8.97	113.91
Diluted EPS Before Extra, 1 Yr. Growth %	12.42	-6.46	2.6	-45.51	148.4
Accounts Receivable, 1 Yr. Growth %	-12.08	47.3	-42.09	29.4	47.33
Inventory, 1 Yr. Growth %	50.41	6.62	393.46	-8.98	1.36
Net Property, Plant and Equip., 1 Yr. Growth %	0.44	5.96	20.61	2.47	36.8
Total Assets, 1 Yr. Growth %	13.03	3.83	238.06	5.5	6.08
Tangible Book Value, 1 Yr. Growth %	21.15	6.71	30.31	1.72	-3.47
Common Equity, 1 Yr. Growth %	18.43	5.67	310.22	2.7	-1.32
Cash From Operations, 1 Yr. Growth %	159.78	-99.91	62.1K	67.9	-28.37
Capital Expenditures, 1 Yr. Growth %	-27.16	75.4	88.94	-35.7	-19.87
Levered Free Cash Flow, 1 Yr. Growth %	-231.34	-127.5	935.48	-134.39	-66.52
Unlevered Free Cash Flow, 1 Yr. Growth %	-234.25	-126.31	966.93	-137.71	-60.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	30.15	11.14	7.21	24.8	38.29
Gross Profit, 2 Yr. CAGR %	32.12	0.24	-1.66	27.61	53.15
EBITDA, 2 Yr. CAGR %	34.69	-1.06	-3.24	2.08	27.21
EBITA, 2 Yr. CAGR %	36.64	-1.56	-3.57	1.76	27.71
EBIT, 2 Yr. CAGR %	40.84	-5.1	-6.44	-12.81	33.7
Earnings From Cont. Operations, 2 Yr. CAGR %	40.59	0.54	-4.02	-11.21	38.25
Net Income, 2 Yr. CAGR %	38.74	1.92	-3.86	-11.35	38.64
Normalized Net Income, 2 Yr. CAGR %	40.5	-0.99	-5.75	-2.76	32.71
Diluted EPS Before Extra, 2 Yr. CAGR %	38.84	2.05	-2.07	-25.23	16.44
Accounts Receivable, 2 Yr. CAGR %	16.28	13.8	-7.64	-13.44	38.07
Inventory, 2 Yr. CAGR %	37.28	26.64	129.38	111.84	-3.95
Net Property, Plant and Equip., 2 Yr. CAGR %	1.44	3.16	13.05	11.17	18.4
Total Assets, 2 Yr. CAGR %	21.25	8.33	87.36	89.04	5.79
Tangible Book Value, 2 Yr. CAGR %	15.19	13.7	17.92	15.66	-0.91
Common Equity, 2 Yr. CAGR %	19.13	11.87	108.2	105.26	0.67
Cash From Operations, 2 Yr. CAGR %	38.65	-95.04	-23.22	3.13K	9.67
Capital Expenditures, 2 Yr. CAGR %	-18.01	13.03	82.05	10.22	-28.22
Levered Free Cash Flow, 2 Yr. CAGR %	105.31	-40.37	68.73	91.47	-66.07
Unlevered Free Cash Flow, 2 Yr. CAGR %	100.86	-41.02	67.54	103.53	-61.61
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	24.86	26.49	5.58	23.39	22.15
Gross Profit, 3 Yr. CAGR %	26.14	17.69	0.78	15.64	33.68
EBITDA, 3 Yr. CAGR %	29.46	17.74	0.18	-1.7	18.46
EBITA, 3 Yr. CAGR %	30.77	18.43	-0.05	-2.23	18.89
EBIT, 3 Yr. CAGR %	32.86	19.26	-3.22	-12.88	21.63
Earnings From Cont. Operations, 3 Yr. CAGR %	35.88	20.8	0.88	-10.58	24.75
Net Income, 3 Yr. CAGR %	33.1	21.34	1.14	-9.98	24.17
Normalized Net Income, 3 Yr. CAGR %	33.33	18.39	0.6	-6.84	22.31
Diluted EPS Before Extra, 3 Yr. CAGR %	32.45	21.32	2.21	-19.45	11.63
Accounts Receivable, 3 Yr. CAGR %	10.88	25.82	-9.15	3.34	3.35
Inventory, 3 Yr. CAGR %	52.52	26.19	99.28	68.51	65.69
Net Property, Plant and Equip., 3 Yr. CAGR %	2.54	2.93	8.68	9.4	19.13
Total Assets, 3 Yr. CAGR %	17.44	15.14	58.31	54.82	55.92
Tangible Book Value, 3 Yr. CAGR %	13.54	12.29	18.99	12.59	8.89
Common Equity, 3 Yr. CAGR %	16.36	14.46	72.51	64.51	60.79
Cash From Operations, 3 Yr. CAGR %	35.68	-87.79	15.27	-0.34	807.81
Capital Expenditures, 3 Yr. CAGR %	-7.25	5.65	34.15	28.68	-0.89
Levered Free Cash Flow, 3 Yr. CAGR %	61.06	4.5	54.42	0.27	7.07
Unlevered Free Cash Flow, 3 Yr. CAGR %	57.77	1.49	54.82	2.91	17.42
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	23.31	19.2	17.25	25.81	17.62
Gross Profit, 5 Yr. CAGR %	23.13	8.15	13.81	21.56	19.14
EBITDA, 5 Yr. CAGR %	25.98	7.89	14.92	11.2	10.23
EBITA, 5 Yr. CAGR %	28.1	7.79	15.44	11.46	10.24
EBIT, 5 Yr. CAGR %	27.9	5.32	15.08	5.22	10.14
Earnings From Cont. Operations, 5 Yr. CAGR %	31.87	7.06	17.84	6.8	14.43
Net Income, 5 Yr. CAGR %	29.52	7.87	16.86	7.02	14.74
Normalized Net Income, 5 Yr. CAGR %	26.8	6.1	15.66	9.43	12.39
Diluted EPS Before Extra, 5 Yr. CAGR %	28.55	7.19	17.15	-0.05	7.68
Accounts Receivable, 5 Yr. CAGR %	7.74	14.38	3.06	8.34	7.41
Inventory, 5 Yr. CAGR %	27.59	25.31	79.57	55.25	48.8
Net Property, Plant and Equip., 5 Yr. CAGR %	1.83	3.59	6.62	6.15	12.47
Total Assets, 5 Yr. CAGR %	14.49	12.33	41.57	40.4	34.79
Tangible Book Value, 5 Yr. CAGR %	13.45	11.19	15.27	13.63	10.79
Common Equity, 5 Yr. CAGR %	15	12.59	46.85	44.58	39.07
Cash From Operations, 5 Yr. CAGR %	31.68	-71.82	8.05	13.73	12.99
Capital Expenditures, 5 Yr. CAGR %	34.98	39.55	21.47	7.45	4.46
Levered Free Cash Flow, 5 Yr. CAGR %	77.14	-12.79	63.58	33.14	-15.28
Unlevered Free Cash Flow, 5 Yr. CAGR %	66.67	-13.94	61.12	34.06	-10.85